FR3023166B1 - Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire - Google Patents

Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire Download PDF

Info

Publication number
FR3023166B1
FR3023166B1 FR1456529A FR1456529A FR3023166B1 FR 3023166 B1 FR3023166 B1 FR 3023166B1 FR 1456529 A FR1456529 A FR 1456529A FR 1456529 A FR1456529 A FR 1456529A FR 3023166 B1 FR3023166 B1 FR 3023166B1
Authority
FR
France
Prior art keywords
pectin
prevention
treatment
pharmaceutical composition
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1456529A
Other languages
English (en)
Other versions
FR3023166A1 (fr
Inventor
Cedric Garcia
Nathalie Larnaudie
Evelyne Ollivier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Rivadis Sas
Original Assignee
Laboratoires Rivadis Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Rivadis Sas filed Critical Laboratoires Rivadis Sas
Priority to FR1456529A priority Critical patent/FR3023166B1/fr
Publication of FR3023166A1 publication Critical patent/FR3023166A1/fr
Application granted granted Critical
Publication of FR3023166B1 publication Critical patent/FR3023166B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1456529A 2014-07-07 2014-07-07 Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire Active FR3023166B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1456529A FR3023166B1 (fr) 2014-07-07 2014-07-07 Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1456529 2014-07-07
FR1456529A FR3023166B1 (fr) 2014-07-07 2014-07-07 Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire

Publications (2)

Publication Number Publication Date
FR3023166A1 FR3023166A1 (fr) 2016-01-08
FR3023166B1 true FR3023166B1 (fr) 2018-01-12

Family

ID=51659852

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1456529A Active FR3023166B1 (fr) 2014-07-07 2014-07-07 Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire

Country Status (1)

Country Link
FR (1) FR3023166B1 (fr)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393678A (en) * 1966-01-03 1968-07-23 Purex Corp Ltd Tampons and the like
GB9208731D0 (en) * 1992-04-22 1992-06-10 Squibb & Sons Inc Hydrocolloid wound gel
JP2002226378A (ja) * 2001-01-30 2002-08-14 Mikasa Seiyaku Co Ltd 再上皮化促進剤
WO2003092645A2 (fr) * 2002-04-30 2003-11-13 Societe D'extraction Des Principes Actifs (Vincience Sa) Composition cosmetique comprenant des mono- ou poly-saccharides
JP4712380B2 (ja) * 2002-07-26 2011-06-29 三笠製薬株式会社 外用剤
JP2004107295A (ja) * 2002-09-20 2004-04-08 National Agriculture & Bio-Oriented Research Organization ヒスタミン遊離抑制剤
WO2004100966A1 (fr) * 2003-05-16 2004-11-25 Bbk Bio Corporation Preparation servant a empecher le contact de substances pathogenes avec des organismes vivants
JP2013155120A (ja) * 2012-01-27 2013-08-15 Mikasa Seiyaku Co Ltd 皮膚潰瘍治癒促進外用剤

Also Published As

Publication number Publication date
FR3023166A1 (fr) 2016-01-08

Similar Documents

Publication Publication Date Title
WO2015077503A8 (fr) Composés inhibiteurs de l'autotaxine
EP3686200A3 (fr) Composés hétérocycles bicycliques et leurs utilisations en thérapie
CL2013001654A1 (es) Compuestos derivados de 6-amino-2-fenilamino-1h-bencimidazol-5-carboxamida; composicion farmaceutica; y su uso en el tratamiento y/o prevencion de las enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
IN2015DN00376A (fr)
HK1259031A1 (zh) 使用治療有效量的活化脂肪酸預防、治療和逆轉疾病
HK1250629A1 (zh) 用於治療人乳頭狀瘤病毒皮膚感染的含乙酰水楊酸的組合物和醫療裝置
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
MA52644A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA40846A (fr) Compositions d'acides gras et d'esters d'acides gras auto-micellisantes, ainsi que leur utilisation dans le traitement d'états pathologiques
MA41996A (fr) Utilisation de triméthazine dans la préparation de médicaments pour la prévention et le traitement de maladies hépatiques
IL274578A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
MA39447B1 (fr) Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
MA42611A (fr) Traitement combiné comprenant l'administration de 2-amino-3,5,5-trifluoro-3,4,5,6-tétrahydropyridines
MA39448B1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
MA39912B1 (fr) Dérivés de 2-aryl-4-hydroxy-1,3-thiazole comme antagonistes du trpm8, et leur utilisation dans le traitement de la neuralgie, de la douleur, de la bpco et de l'asthme.
IL272495A (en) Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases
WO2016191458A3 (fr) Compositions pharmaceutiques ayant un effet sur l'état d'oxydoréduction mitochondriale et méthodes de traitement associées
MA51278A (fr) Utilisation d'un extrait végétal en tant qu'agent actif dans le traitement de maladies dermatologiques
MA50458A (fr) Formulations topiques destinées au traitement d'affections dermatologiques comprenant la calvitie hippocratique
FR3023166B1 (fr) Utilisation d'une composition pharmaceutique renfermant une pectine a titre de principe actif, dans la prevention et/ou le traitement des lesions cutanees impliquant un caractere inflammatoire
WO2016144706A3 (fr) Composés inhibiteurs de l'autotaxine et leurs utilisations
MA49148A (fr) Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
MA45678A (fr) Utilisation du xibornol en tant qu'agent actif dans le traitement d'infections virales
MA45378A (fr) Compositions comprenant du timolol et leur utilisation dans le traitement de la rosacée par administration topique

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20160108

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11